2008
DOI: 10.1021/jo701873t
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis of Analogues of (E)-1-Hydroxy-2-methylbut-2-enyl 4-Diphosphate, an Isoprenoid Precursor and Human γδ T Cell Activator

Abstract: Abstract:(E)-1-hydroxy-2-methyl-but-2-enyl 4-diphosphate (HMBPP) is an intermediate in the nonmevalonate pathway for the biosynthesis of isoprenoids and also serves as a very strong activator of human  T cells expressing V9/V2 receptors. This paper describes the synthesis of analogues of HMBPP, in which the diphosphate group is replaced by potential isosteric moieties, i.e. carbamate, N-acyl-N'-oxy sulfamate or aminosulfonyl carbamate functionalities. The potential of the synthesized analogues to stimulat… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
16
0
1

Year Published

2010
2010
2020
2020

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 15 publications
(18 citation statements)
references
References 35 publications
1
16
0
1
Order By: Relevance
“…Therefore, we decided to use the allylic hydroxyl group of 1 in reactions with commercially available isocyanates to generate a library of carbamates. 30 In an identical manner to the amide library, a virtual collection of potential carbamates was initially generated using the software Reactor 40 and Instant JChem 41 coupled with a list of commercially available isocyanates (315 in total). 39 Analysis of the in silico physicochemical properties (MW, HBD, HBA, Log P, Log D5.5) of the virtual library 45 identified those members that were compliant with drug-like properties.…”
Section: Resultsmentioning
confidence: 99%
“…Therefore, we decided to use the allylic hydroxyl group of 1 in reactions with commercially available isocyanates to generate a library of carbamates. 30 In an identical manner to the amide library, a virtual collection of potential carbamates was initially generated using the software Reactor 40 and Instant JChem 41 coupled with a list of commercially available isocyanates (315 in total). 39 Analysis of the in silico physicochemical properties (MW, HBD, HBA, Log P, Log D5.5) of the virtual library 45 identified those members that were compliant with drug-like properties.…”
Section: Resultsmentioning
confidence: 99%
“…Substrate analogues that bind to IspG or IspH but cannot be turned over could be potent inhibitors of interest as new anti‐infective drug leads and herbicides. Replacement of the diphosphate group with carbamate (compounds 14 ), N ‐acyl‐ N ′‐oxysulfamate (compounds 15 ), or aminosulfonyl carbamate groups (compounds 16 ; Scheme ) resulted in only weak inhibitory effects against IspH or IspG 84. The substitution of the diphosphate group also abolished the ability of these compounds to activate human Vγ2Vδ2 T cells ( 4 is an activator at ca.…”
Section: Inhibitors Of Isph and Ispgmentioning
confidence: 99%
“…The Fe 4 S 4 cluster, while catalytically active, is thus relatively labile, as also found for example in aconitase and in pyruvate-formate lyase activating enzyme 12. To date, there has been only one report of IspH inhibitors,13 with IC 50 values of ~1–2 mM having been obtained. Here, we report progress aimed at obtaining more potent inhibitors.…”
Section: Introductionmentioning
confidence: 97%